David J. Bell - Publications

Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women.

Journal: Vaccine

Published: February 24, 2021

Protective effects of intermedin/adrenomedullin-2 in a cellular model of human pulmonary arterial hypertension.

Journal: Peptides

Published: October 21, 2019

Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding-delayed add-back onset does not improve bleeding pattern.

Journal: Reproductive sciences (Thousand Oaks, Calif.)

Published: March 07, 2019

Changing medical students' attitudes to and knowledge of deafness: a mixed methods study.

Journal: BMC medical education

Published: September 24, 2018

Docbate: A National Medical Student Debate.

Journal: Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry

Published: June 10, 2016

Plasma levels of intermedin (adrenomedullin-2) in healthy human volunteers and patients with heart failure.

Journal: Peptides

Published: September 18, 2015

Endothelium-derived intermedin/adrenomedullin-2 protects human ventricular cardiomyocytes from ischaemia-reoxygenation injury predominantly via the AM₁ receptor.

Journal: Peptides

Published: September 07, 2015

Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women.

Journal: Human reproduction (Oxford, England)

Published: August 17, 2015

How should teaching on whole person medicine, including spiritual issues, be delivered in the undergraduate medical curriculum in the United Kingdom?

Journal: BMC medical education

Published: October 20, 2014

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

Journal: The Lancet. Infectious diseases

Published: December 03, 2013

Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP.

Journal: Current protein & peptide science

Published: September 12, 2012

AM₁-receptor-dependent protection by intermedin of human vascular and cardiac non-vascular cells from ischaemia-reperfusion injury.

Journal: The Journal of physiology

Published: December 21, 2011